Sanofi, which previously reported slower timelines than most other drugmakers working on COVID-19 vaccines, now purports it may receive approval for two vaccines in 2021, according to STAT. Phase 1/2 ...
NJ Bio Bridges the Translation Research Gap with the Asset Purchase and Integration of L2P® Services
PRINCETON, N.J., November 06, 2025--(BUSINESS WIRE)--NJ Bio, Inc., a premier contract research and clinical manufacturing service provider in Princeton, New Jersey has announced the asset purchase and ...
Announcing a new article publication for BIO Integration journal. In this article the authors Chunxiong Zheng, Mingqiang Li and Jianxun Ding from Sun Yat-sen University, Guangzhou, China and Changchun ...
Synonymous codons are used non-randomly in the transcriptome to shape multiple aspects of translation. Optimal codons are associated with more efficient translation and correspond to cognate tRNA ...
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
Cell coding company bit.bio announces an expansion to its product portfolio to accelerate research into neurodegenerative diseases. Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS ...
NJ Bio Bridges the Translation Research Gap with the Asset Purchase and Integration of L2P® Services
NJ Bio, Inc., a premier contract research and clinical manufacturing service provider in Princeton, New Jersey has announced the asset purchase and full integration of the research services of L2P ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback